Print

Alzheimer's Drug Discovery Foundation and Elan Pharmaceuticals (ELN) Announce Winners of Second Annual Novel Discovery Award Program  
3/1/2007 12:45:53 PM

NEW YORK, NY -- (MARKET WIRE) -- March 01, 2007 -- The Alzheimer's Drug Discovery Foundation (ADDF), a biomedical venture philanthropy founded by the Estée Lauder family, and Elan Pharmaceuticals, Inc., a neuroscience-based biotechnology company, are pleased to announce the winners of their second annual research award program, Novel Approaches to Drug Discovery for Alzheimer's Disease. Six recipients were selected from a highly competitive pool of 32 scientists from 6 countries
//-->